Haemonetics bolsters electrophysiology lead as large-bore closure device hits 0% bleeding milestone
Haemonetics (NYSE:HAE) announced new clinical data demonstrating superior safety for its vascular closure technology, just weeks after receiving expanded U.S. regulatory clearance to address a wider range of complex cardiac procedures.










